Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

With ABBOTINDIA's revenues expected to fall below the previous year's, investors are likely to approach the stock with caution. Declining revenues can negatively affect profitability, which makes it harder for the company to maintain investor confidence and perform well in the market.

Financial Ratios:

currentRatio 0.00000
forwardPE 35.28706
debtToEquity 4.64600
earningsGrowth 0.11500
revenueGrowth 0.11600
grossMargins 0.45281
operatingMargins 0.24512
trailingEps 683.16000
forwardEps 0.00000

ABBOTINDIA's positive growth in earnings and revenue suggests the company is on track to expand its business. These indicators highlight a healthy financial performance, with ABBOTINDIA expected to increase its market presence and profitability.
With positive gross and operating margins, ABBOTINDIA demonstrates its profitability and efficiency. These metrics show that the company is managing costs well while generating strong revenue, highlighting robust financial health.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

Price projections for ABBOTINDIA have steadily increased, reflecting growing optimism about the company's future. This trend suggests that analysts believe ABBOTINDIA is well-positioned for continued success.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


The recent buy bias from analysts suggests ABBOTINDIA is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, ABBOTINDIA appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.